A $1 Billion Pennsylvania cell therapy site investment bolsters domestic manufacturing, creating 500 skilled biomanufacturing ...

Eli Lilly & CSL seal a deal for clazakizumab partitions rights to maximize lifecycle value. CSL retains ESKD focus as Lilly ...

In this episode of Ask the Expert, Susan J. Schniepp, Nelson Labs, and Siegfried Schmitt, Parexel, discuss the benefits of orphan drug development and how a mid-sized company can work with regulators ...

Fujifilm’s £400m (US $547m) Teesside expansion adds 19,000L single-use capacity and an innovation center to boost global ...

Etalytics’ etaONE achieved a 21% cooling-electricity reduction in three months by autonomously orchestrating chillers, cooling towers, and pumps using real-time pressure and environmental data.

Iambic’s physics-informed NeuralPLexer is intended to enhance protein–ligand modeling, enabling broader exploration of ...

Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...

One challenge is limited commercial synergy. Rare disease markets are often fragmented, with small prescriber bases and ...

Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support ...

Carter emphasizes that women are currently serving as primary “thought leaders” in the advancement of precision medicine . In ...

Márcio Temtem, Hovione, discusses how to tackle pharma complexity via regional growth in the US, Ireland, and Portugal, using digital tools to accelerate development.

PharmTech spoke with women working in the pharmaceutical industry about the innovations they are seeing in bio/pharma and the ...